Irisin could contribute to the modulation of obesity-induced inflammatory/anti-inflammatory balance by increasing CD206 and interleukin 10 and decreasing tumour necrosis factor alpha and leptin[14]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.